Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2025 R&D 100 Award Winners
    • 2025 Professional Award Winners
    • 2025 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Beckman Coulter partners with Wyatt on particle characterization

By R&D Editors | March 4, 2014

Beckman Coulter Life Sciences has announced an agreement with Wyatt Technology Corp. enabling collaboration on products, applications and technical development.  The partnership brings together Wyatt’s expertise in protein characterization, light scattering and biophysics with Beckman Coulter’s expertise in particle counting, particle characterization and cell viability measurement.

“We are excited to be working with Wyatt Technology, as they have strong brand recognition in sectors such as biopharmaceuticals. Their products are already known by our Vi-Cell and analytical ultracentrifuge customers,” said Matt Rhyner, PhD, senior marketing manager, Beckman Coulter Life Sciences.  “Partnering with Wyatt Technology, a storied company renowned for their technology and products, will help us expand our portfolio and presence in the particle market.”

The accord specifies that the companies will develop products for nanoparticle characterization to be marketed under the Beckman Coulter Life Sciences brand, and opens the door for future collaborations on product development and the sharing of business practices.

“Collaboration with Beckman Coulter has been of interest since getting to know Wallace Coulter in the late 1970s,” explained Dr. Philip Wyatt, chief executive officer, Wyatt Technology. “Entering into this agreement with a company that has the history and strong product portfolio of Beckman Coulter, we see a great opportunity to expand market access while retaining the strength and character upon which our customers rely.”

Taken together with the recent addition of the MET ONE and HIAC brands, the accord with Wyatt enables Beckman Coulter to provide a greater range of particle characterization solutions and to further enhance their world-class customer support and service.

Currently being introduced at Pittcon 2014 (Booth 1964), the Multisizer 4e COULTER COUNTER is the latest Beckman Coulter innovation in particle counting and characterization, measuring particles as small as 0.2 microns.

Source:

Beckman Coulter Particle Characterization and Counting
Beckman Coulter Life Sciences

Related Articles Read More >

Parallel Bio’s embraces in-house drug development as FDA backs animal testing alternatives
R&D 100 Winner Spotlight: A closer look at Thermo Fisher Scientific’s trio of R&D 100 wins in 2025
Life sciences M&A hit $240B in 2025 as Big Pharma preps for patent cliffs
Hansoh Bio signs 32,000-sq.-ft. lab lease at Research Square in Rockville, MD
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2025 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

R&D 100 Awards
Research & Development World
  • Subscribe to R&D World Magazine
  • Sign up for R&D World’s newsletter
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2026 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2025 R&D 100 Award Winners
    • 2025 Professional Award Winners
    • 2025 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE